VANCOUVER, British Columbia, June 26, 2017 /PRNewswire/ --
MYM Nutraceuticals Inc. (CSE: MYM) (OTC:MYMMF), is extremely pleased to announce that CBC National News is featuring MYM's new Weedon Greenhouse, Cannabis School and Cannabis Museum Project in Weedon, Quebec.
MYM Executives Erick Factor, Rob Gietl and MYM subsidiary CannaCanada Inc. Executives Yann Lafleur and Antonio Bramante, along with representatives of the City of Weedon, will be interviewed today by CBC National News. Yann Lafleur, President of CannaCanada Inc., is the nephew of Canadian hockey super star Guy Lafleur.
MYM has gained national attention since signing an exclusive deal with the Municipality of Weedon, Québec to build a 1.5 million-square-foot cannabis production facility consisting of fifteen 100,000-square-foot greenhouses. Once the entire project is completed and licensed, it would be one of the largest grow operations in the world, with the potential to produce over 150,000 kilograms of cannabis per year or $750,000,000 annually.
This is a first of its kind partnership where a municipality has partnered with a cannabis company to build a major production facility. The agreement is unique as Weedon will purchase the 329 acres of land for MYM to build the project on and after 18 months MYM has the right to purchase the entire 329 acres from the City for $630,000.
The Weedon Project will also include a first of its kind 100,000 sq. ft. cannabis education center for industry training and a cannibis museum. It will be the first cannabis museum, education centre, and research and development building for testing and clinical studies on cannabis.
The cannabis museum will be a walk through the history of medicinal cannabis and hemp. The education centre will be an institute to provide certification in all areas of expertise in cannabis production, testing and product development. Part of the complex will be an R&D lab for testing, strain development and identifying the ailments that each strain treats. The facility will have a 2500 person auditorium and a hotel with twenty-two 1000 sq. ft. rooms. This project will drive tourism and provide economic growth in the City of Weedon.
MYM is continuing to negotiate acquisitions of complimentary businesses and assets in the technology, Nutraceuticals and CBD nutraceutical sector and is currently in talks with other innovative companies.
MYM Nutraceuticals Inc. (CSE:MYM)(OTC:MYMMF)(FRA:OMY) is a public company trading on the Canadian Stock Exchange whose primary focus is developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
You can email Mr. Brown here: http://www.mymarijuana.ca/contact-us/
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
MYM Investor Relations Contact info:
SOURCE MYM Nutraceuticals Inc.